Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients - 18/04/17
Abstract |
Background |
Anagen effluvium with reversible scalp alopecia is a known side effect of chemotherapy. However, there are an increasing number of reports in the literature documenting permanent alopecia in patients treated with taxanes.
Objective |
We sought to describe the clinicopathologic features in breast cancer patients who underwent treatment with taxanes and adjuvant hormonal chemotherapy.
Methods |
We reviewed the clinical and histopathologic information of a cohort of 10 patients treated with taxanes and adjuvant hormonal chemotherapy.
Results |
We have observed 3 types of clinical patterns of alopecia (types A, B, and C), and have validated the histopathologic features showing alopecia areata–like and female pattern hair loss.
Limitations |
The study was based on a small sample size and retrospective retrieval of clinical information and histopathologic review of posttreatment slides.
Conclusions |
We hypothesize a clinicopathologic model of hair follicle cycle disruption in response to the chemoinflammatory and hormonal insults to the hair follicles resulting in permanent alopecia. Clinicopathologic correlation is paramount to the understanding of the morphobiologic pathways in chemotherapy-induced alopecia caused by taxanes and adjuvant hormonal treatment.
Le texte complet de cet article est disponible en PDF.Key words : alopecia, breast cancer, clinicopathologic correlation, coadjuvant hormonal therapy, histopathology, tamoxifen, taxanes
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
|
| This work was approved by Guy's and St Thomas' NHS Trust, London, United Kingdom, Research and Development number RJ114/N103. |
|
| Reprints not available from the authors. |
Vol 76 - N° 5
P. 948-957 - mai 2017 Retour au numéro
Article précédent
- Congenital melanocytic nevi in young children: Histopathologic features and clinical outcomes
- Emily A. Simons, Jennifer T. Huang, Birgitta Schmidt
- The burden of skin disease in the United States
- Henry W. Lim, Scott A.B. Collins, Jack S. Resneck, Jean L. Bolognia, Julie A. Hodge, Thomas A. Rohrer, Marta J. Van Beek, David J. Margolis, Arthur J. Sober, Martin A. Weinstock, David R. Nerenz, Wendy Smith Begolka, Jose V. Moyano
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?